Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1963 3
1965 1
2002 2
2003 6
2004 1
2005 3
2006 2
2007 2
2008 4
2009 1
2010 7
2011 6
2012 10
2013 12
2014 18
2015 18
2016 12
2017 8
2018 4
2019 15
2020 16
2021 17
2022 21
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion.
Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K; POPCORN Investigators. Soga Y, et al. Among authors: kawasaki d. J Am Heart Assoc. 2023 Jan 3;12(1):e025677. doi: 10.1161/JAHA.122.025677. Epub 2022 Dec 30. J Am Heart Assoc. 2023. PMID: 36583431 Free PMC article.
Application of first-generation high- and low-dose drug-coated balloons to the femoropopliteal artery disease: a sub-analysis of the POPCORN registry.
Fujihara M, Takahara M, Soga Y, Iida O, Kawasaki D, Tomoi Y, Tsubakimoto Y, Ogata K, Karashima E, Kato T, Kobayashi Y, Kaneko N, Sasaki S, Ichihashi K. Fujihara M, et al. Among authors: kawasaki d. CVIR Endovasc. 2023 Aug 10;6(1):41. doi: 10.1186/s42155-023-00390-x. CVIR Endovasc. 2023. PMID: 37561267 Free PMC article.
Three-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.
Yamauchi Y, Takahara M, Shintani Y, Iida O, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Hirano K, Soga Y, Tsubakimoto Y, Yokoi H, Miyamoto A, Nakamura M. Yamauchi Y, et al. Among authors: kawasaki d. Circ Cardiovasc Interv. 2020 Aug;13(8):e009168. doi: 10.1161/CIRCINTERVENTIONS.120.009168. Epub 2020 Jul 29. Circ Cardiovasc Interv. 2020. PMID: 32755323 No abstract available.
One-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.
Yamauchi Y, Takahara M, Shintani Y, Iida O, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Hirano K, Yokoi H, Miyamoto A, Nakamura M; OMOTENASHI investigators. Yamauchi Y, et al. Among authors: kawasaki d. Circ Cardiovasc Interv. 2019 Jan;12(1):e007441. doi: 10.1161/CIRCINTERVENTIONS.118.007441. Circ Cardiovasc Interv. 2019. PMID: 30616363 No abstract available.
A Novel Angiographic Risk Score for Femoropopliteal Interventions.
Iida O, Takahara M, Soga Y, Fujihara M, Kawasaki D, Hirano K, Choi D, Mano T. Iida O, et al. Among authors: kawasaki d. J Endovasc Ther. 2020 Dec;27(6):967-973. doi: 10.1177/1526602820948472. Epub 2020 Aug 19. J Endovasc Ther. 2020. PMID: 32813589
One-year results for Japanese patients in RANGER II SFA.
Soga Y, Fujihara M, Yamamoto Y, Nakamura S, Iida O, Kawasaki D, Urasawa K, Ando H, Mori S, Suzuki K, Horie K, Diaz-Cartelle J, Kozuki A. Soga Y, et al. Among authors: kawasaki d. Heart Vessels. 2022 Apr;37(4):568-573. doi: 10.1007/s00380-021-01947-3. Epub 2021 Sep 23. Heart Vessels. 2022. PMID: 34557931 Clinical Trial.
Clinical Impact of Intravascular Ultrasound-Guided Fluoropolymer-Based Drug-Eluting Stent Implantation for Femoropopliteal Lesions.
Tsujimura T, Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, Ichihashi S, Kozuki A, Nanto S, Sakata Y, Mano T; CAPSICUM Investigators. Tsujimura T, et al. Among authors: kawasaki d. JACC Cardiovasc Interv. 2022 Aug 8;15(15):1569-1578. doi: 10.1016/j.jcin.2022.06.012. JACC Cardiovasc Interv. 2022. PMID: 35926923 Free article.
170 results